CSIMarket
 
Endra Life Sciences Inc  (NASDAQ: NDRA)
 
Price: $5.3000 $-0.30 -5.357%
Day's High: $5.67110013961792 Week Perf: -8.38 %
Day's Low: $ 5.03 30 Day Perf: 18.04 %
Volume (M): 23,857 52 Wk High: $ 9.85
Volume (M$): $ 0 52 Wk Avg: $4.95
Open: $5.32 52 Wk Low: $2.96



 Market Capitalization (Millions $) 13
 Shares Outstanding (Millions) 2
 Employees 4
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 3

Business Description


Endra Life Sciences Inc is a medical technology company that specializes in the development and commercialization of innovative imaging solutions. The company focuses on combining ultrasound technology with advanced algorithms to provide non-invasive, accurate, and cost-effective medical imaging solutions.

Endra Life Sciences' flagship product is the Thermo Acoustic Enhanced UltraSound (TAEUS) system, which uses a combination of ultrasound and thermal mapping to visualize tissue function and assess various diseases. This technology has the potential to improve diagnosis and treatment monitoring for conditions such as liver disease, cardiovascular disease, and cancer.

The company aims to provide a non-invasive alternative to invasive and expensive procedures, reducing healthcare costs and improving patient outcomes. Endra Life Sciences is committed to advancing medical imaging technology and revolutionizing the way diseases are diagnosed and managed.


   Company Address: 3600 Green Court Ann Arbor 48105 MI
   Company Phone Number: 335-0468   Stock Exchange / Ticker: NASDAQ NDRA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DRIO        2.49% 
DXCM        4.95% 
GCTK   -26.43%    
MDT        2.47% 
PROF   -15.59%    
VANI   -5.7%    
• View Complete Report
   



Business Update

ENDRA Life Sciences Pioneering Progress in Liver Health with TAEUS Technology,

Published Thu, Nov 20 2025 3:49 PM UTC

Innovation in Liver Health: ENDRA Life Sciences TAEUS Device Shows Promising Results ANN ARBOR, Mich. ENDRA Life Sciences Inc. (NASDAQ: NDRA), a trailblazer in the realm of biomarker imaging technologies, is drawing significant attention with its recent advancements in the field of liver health. The company, recognized for its innovative methods in addressing metabolic dy...

Business Update

“ENDRA Life Sciences Melding Health Innovation with Digital Asset Strategy for Tomorrow’s Solutions”,

Published Thu, Nov 13 2025 1:28 PM UTC

ENDRA Life Sciences Inc. (NASDAQ: NDRA), based in Ann Arbor, Michigan, is at the forefront of revolutionizing medical imaging technologies for the detection and monitoring of metabolic liver diseases. But the company’s ambition doesn’t end with healthcare technology; they are also strategically embracing the emerging digital asset landscape. This dual focus not only refl...

Business Update

ENDRA Life Sciences Inc. (NASDAQ NDRA), based in Ann Arbor, Michigan, has recently undertaken significant s...

Published Thu, Oct 23 2025 1:59 PM UTC

ENDRA Life Sciences: A Transformative Shift with New Investments and Regulatory Compliance Boost ENDRA Life Sciences Inc. (NASDAQ: NDRA), based in Ann Arbor, Michigan, has recently undertaken significant steps that could bolster its position in the imaging technology sector and enhance its financial standing. Here, we explore the implications of the company’s latest develo...

Business Update

Endra Life Sciences Bounces Back Regaining Compliance Amidst Market Struggles

Published Mon, Nov 25 2024 12:47 AM UTC

In a notable turn of events for Endra Life Sciences Inc. the Ann Arbor-based innovator of Thermo Acoustic Enhanced UltraSound (TAEUS), the company has successfully reclaimed compliance with the Nasdaq s minimum bid price requirement. On November 21, 2024, Endra announced that it received a notification from the Nasdaq Listing Qualifications Department confirming adherence to...

Business Update

Endra Life Sciences Reclaims Nasdaq Compliance Amidst Competitive Landscape Challenges

Published Sat, Nov 23 2024 2:48 AM UTC

In a notable development for the financial health and operational integrity of Endra Life Sciences Inc. (NASDAQ: NDRA), the company recently announced that it has successfully regained compliance with The Nasdaq Stock Market s minimum bid price requirement. This milestone is significant, as it reinforces Endra s commitment to meeting the stringent regulatory standards and ma...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 2.08
PEG (TTM) -

Financial Strength Current
Quick Ratio 7.04
Working Capital Ratio 7.1
Leverage Ratio (MRQ) 0.26
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -7.16 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 2.24 $
Book Value 2.55 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,479,162
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.